Pegah Abdollahi
- Research coordinator; PhD
Publications 2024
Advances and challenges in anti-cancer vaccines for multiple myeloma
Front Immunol, 15, 1411352
DOI 10.3389/fimmu.2024.1411352, PubMed 39161773
Publications 2023
Id-neoantigen vaccine induces therapeutic CD8+ T cells against multiple myeloma: H chain-loss escapees cause FLC MM
J Immunother Cancer, 11 (8)
DOI 10.1136/jitc-2023-006944, PubMed 37607769
Publications 2022
Phosphatases of regenerating liver are key regulators of metabolism in cancer cells - role of Serine/Glycine metabolism
Curr Opin Clin Nutr Metab Care, 25 (1), 50-55
DOI 10.1097/MCO.0000000000000797, PubMed 34725313
Highly expressed genes in multiple myeloma cells - what can they tell us about the disease?
Eur J Haematol, 109 (1), 31-40
DOI 10.1111/ejh.13766, PubMed 35276027
The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells
Oncotarget, 13, 1175-1186
DOI 10.18632/oncotarget.28300, PubMed 36268559
Publications 2021
Phosphatase of regenerating liver-3 regulates cancer cell metabolism in multiple myeloma
FASEB J, 35 (3), e21344
DOI 10.1096/fj.202001920RR, PubMed 33566385
Targeting phosphoglycerate dehydrogenase in multiple myeloma
Exp Hematol Oncol, 10 (1), 3
DOI 10.1186/s40164-020-00196-w, PubMed 33397437
PRL-3 induces a positive signaling circuit between glycolysis and activation of STAT1/2
FEBS J, 288 (23), 6700-6715
DOI 10.1111/febs.16058, PubMed 34092011
Publications 2020
Protein tyrosine phosphatases in multiple myeloma
Cancer Lett, 501, 105-113
DOI 10.1016/j.canlet.2020.11.042, PubMed 33290866
Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade
J Immunother Cancer, 8 (1)
DOI 10.1136/jitc-2020-000610, PubMed 32409420
Publications 2018
Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration
Exp Hematol Oncol, 7, 8
DOI 10.1186/s40164-018-0100-2, PubMed 29651360
Publications 2017
Phosphatase of regenerating liver-3 is expressed in acute lymphoblastic leukemia and mediates leukemic cell adhesion, migration and drug resistance
Oncotarget, 9 (3), 3549-3561
DOI 10.18632/oncotarget.23186, PubMed 29423065
Publications 2016
Src Family Kinases Are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3
Mol Cancer Res, 15 (1), 69-77
DOI 10.1158/1541-7786.MCR-16-0212, PubMed 27698077
The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells
Oncotarget, 7 (19), 27295-306
DOI 10.18632/oncotarget.8422, PubMed 27036022
Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration
J Transl Med, 14, 71
DOI 10.1186/s12967-016-0830-z, PubMed 26975394
Publications 2015
Silibinin affects tumor cell growth because of reduction of stemness properties and induction of apoptosis in 2D and 3D models of MDA-MB-468
Anticancer Drugs, 26 (5), 487-97
DOI 10.1097/CAD.0000000000000205, PubMed 25603020